
Journal of Medicinal Chemistry p. 942 - 949 (1995)
Update date:2022-08-04
Topics:
Perrone, Roberto
Berardi, Francesco
Colabufo, Nicola A.
Leopoldo, Marcello
Tortorella, Vincenzo
et al.
Several 4-alkyl-1-arylpiperazines that present a tetralin moiety on the terminal part of the side chain were synthesized in order to increase the selectivity on the 5-HT1A versus D-2, α1, ?, and other 5-HT receptors.Many changes have been effected on previous structures of type 3 (1-aryl-4-<3-(1,2-dihydronaphthalen-4-yl)-n-propyl>piperazines).Several synthetic procedures were followed to obtain the final products, depending on the presence or absence of a double bond, as well as of heteroatom on the side chain.In the first case versatile use of Grignard reaction was made, whereas in the second one usual synthetic ways were applied.Final compounds were evaluated for in vitro activity on dopamine D-1 and D-2, serotonin 5-HT1A, 5-HT1B, 5-HT1C, and 5-HT2, α1 adrenergic, and ? receptors by radioreceptor binding assay.For the 2-MeO-Ph, 2-pyridyl, and unsubstituted phenyl N-piperazine derivatives, low IC50 values (0.3 nM) on 5-HT1A receptors and high selectivity values were observed.
View MoreLishui Nanming Chemical Co., Ltd(expird)
Contact:+86-0578-2134101,2697830
Address:No.19 Tongji Road Shuige Industrial zone
Contact:+86-511-88790000
Address:338 North Yushan Rd, Zhenjiang, Jiangsu 212016
Contact:+86-575-82733999 0575-82732999
Address:hangzhou gulf fine chemical zone,shangyu city,zhejiang province
Improve Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Doi:10.1021/jo01287a030
(1967)Doi:10.1016/S0040-4020(01)88878-5
(1992)Doi:10.1016/j.ejmech.2015.05.041
(2015)Doi:10.3390/molecules19022694
(2014)Doi:10.1016/j.bmc.2013.01.003
(2013)Doi:10.1016/j.bmcl.2012.11.058
(2013)